Literature DB >> 7388357

Prostatic cancer: the response to treatment dilemma.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7388357      PMCID： PMC1601068          DOI： 10.1136/bmj.280.6218.883

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  6 in total

1.  Carcinoma of prostate. Correlation between radiologic quantitation of metastases and patient survival.

Authors:  J A Hovsepian; D P Byar
Journal:  Urology       Date:  1975-07       Impact factor: 2.649

2.  Evaluation of melphalan, ICRF-159, and hydroxyurea in metastatic prostate cancer: a preliminary report.

Authors:  L K Kvols; R T Eagan; R P Myers
Journal:  Cancer Treat Rep       Date:  1977 Mar-Apr

3.  Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin.

Authors:  C Merrin; W Etra; Z Wajsman; G Baumgartner; G Murphy
Journal:  J Urol       Date:  1976-01       Impact factor: 7.450

4.  Combined serum and bone marrow radioimmunoassays for prostatic acid phosphatase.

Authors:  J F Cooper; A Foti; H Herschman
Journal:  J Urol       Date:  1979-10       Impact factor: 7.450

5.  Reliability of bone marrow acid phosphatase as a parameter of metastatic prostatic cancer.

Authors:  J E Pontes; B Choe; N Rose; J M Pierce
Journal:  J Urol       Date:  1979-08       Impact factor: 7.450

6.  Treatment of metastatic endocrine-unresponsive carcinoma of the prostate gland with multiagent chemotherapy: indicators of response to therapy.

Authors:  D F Paulson; W R Berry; E B Cox; A Walker; J Laszlo
Journal:  J Natl Cancer Inst       Date:  1979-09       Impact factor: 13.506
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.